Anti-LBR monoclonal antibody

Pre-made anti-LBR monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LBR/LBR products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1071-Ab-1/ GM-Tg-hg-IP1071-Ab-2Anti-Human LBR monoclonal antibodyHuman
GM-Tg-rg-IP1071-Ab-1/ GM-Tg-rg-IP1071-Ab-2Anti-Rat LBR monoclonal antibodyRat
GM-Tg-mg-IP1071-Ab-1/ GM-Tg-mg-IP1071-Ab-2Anti-Mouse LBR monoclonal antibodyMouse
GM-Tg-cynog-IP1071-Ab-1/ GM-Tg-cynog-IP1071-Ab-2Anti-Cynomolgus/ Rhesus macaque LBR monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1071-Ab-1/ GM-Tg-felg-IP1071-Ab-2Anti-Feline LBR monoclonal antibodyFeline
GM-Tg-cang-IP1071-Ab-1/ GM-Tg-cang-IP1071-Ab-2Anti-Canine LBR monoclonal antibodyCanine
GM-Tg-bovg-IP1071-Ab-1/ GM-Tg-bovg-IP1071-Ab-2Anti-Bovine LBR monoclonal antibodyBovine
GM-Tg-equg-IP1071-Ab-1/ GM-Tg-equg-IP1071-Ab-2Anti-Equine LBR monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1071-Ab-1/ GM-Tg-hg-IP1071-Ab-2; GM-Tg-rg-IP1071-Ab-1/ GM-Tg-rg-IP1071-Ab-2;
GM-Tg-mg-IP1071-Ab-1/ GM-Tg-mg-IP1071-Ab-2; GM-Tg-cynog-IP1071-Ab-1/ GM-Tg-cynog-IP1071-Ab-2;
GM-Tg-felg-IP1071-Ab-1/ GM-Tg-felg-IP1071-Ab-2; GM-Tg-cang-IP1071-Ab-1/ GM-Tg-cang-IP1071-Ab-2;
GM-Tg-bovg-IP1071-Ab-1/ GM-Tg-bovg-IP1071-Ab-2; GM-Tg-equg-IP1071-Ab-1/ GM-Tg-equg-IP1071-Ab-2
Products NameAnti-LBR monoclonal antibody
Formatmab
Target NameLBR
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LBR monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1071-Ag-1Recombinant multi-species LBR/ DHCR14B/ LMN2R protein
    ORF Viral VectorvGMAP000472Human LBR Adenovirus particle
    ORF Viral VectorpGMAP000472Human LBR Adenovirus plasmid
    ORF Viral VectorpGMLPm002018mouse Lbr Lentivirus plasmid
    ORF Viral VectorvGMLPm002018mouse Lbr Lentivirus particle


    Target information

    Target IDGM-IP1071
    Target NameLBR
    Gene ID3930,98386,89789,700801,490391,101085014,509348,100056997
    Gene Symbol and SynonymsC14SR,DHCR14B,ic,LBR,LMN2R,Nbp60,PHA,PHASK,TDRD18
    Uniprot AccessionQ14739,O08984
    Uniprot Entry NameLBR_HUMAN,LBR_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000143815
    Target ClassificationN/A

    The target: LBR, gene name: LBR, also named as DHCR14B, LMN2R, PHA, PHASK, TDRD18. The protein encoded by this gene belongs to the ERG4/ERG24 family. It localized in the nuclear envelope inner membrane and anchors the lamina and the heterochromatin to the membrane. It may mediate interaction between chromatin and lamin B. Mutations of this gene has been associated with autosomal recessive HEM/Greenberg skeletal dysplasia. Alternative splicing occurs at this locus and two transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.